Likewise, sacubitril/valsartan (LCZ696), an angiotensin receptor neprilysin inhibitor (ARNI), demonstrated notable suppression of NLRP3‐mediated pyroptosis, leading to reduced infarction and improved cardiac function in AMI rats [90]. Here, NLRP3 is linked to infarction.